Streetbeat News

Regulatory

FOX

FOXA

RUM

Despite facing multiple indictments and federal charges, former President Donald Trump continues to lead in national election polls among Republican voters for the 2024 presidential election. However, the latest Morning Consult poll shows Trump's lead slightly shrinking. Ron DeSantis, Nikki Haley, and Vivek Ramaswamy gained in the polls. The second Republican primary debate will be aired on Fox Corporation's Fox Business and livestreamed on Rumble Inc.

Portfolio Pulse from Chris Katje

September 26, 2023 | 11:07 pm

FOX

FOXA

President Biden is currently leading in the polls for the 2024 presidential election, with a potential rematch against Donald Trump or a face-off against Florida Gov. Ron DeSantis. Biden's lead over Trump is narrow, with a one-point advantage. The momentum shift for Biden came after his son, Hunter Biden, was indicted and faced federal charges. Trump has announced he will skip the second Republican primary debate that airs on Fox Business, a unit of Fox Corporation (NASDAQ:FOX)(NASDAQ:FOXA). Biden has increased spending on political advertising recently.

Portfolio Pulse from Chris Katje

September 26, 2023 | 10:36 pm

BTCUSD

GBTC

A group of bipartisan lawmakers have written to SEC Chair Gary Gensler, urging the approval of spot Bitcoin ETPs. The letter references a recent court ruling that upheld Grayscale's stance that the SEC violated the Administrative Procedures Act by denying its application to convert the Grayscale Bitcoin Trust into a spot Bitcoin ETP. The lawmakers argue there is no valid reason to continue denying applications for a regulated spot Bitcoin ETP, which they believe would enhance investor protection. The SEC's decision on the proposed ARK 21Shares Bitcoin ETF has been postponed to January 2024.

Portfolio Pulse from Murtuza Merchant

September 26, 2023 | 9:48 pm

HYZN

Hyzon Motors Inc. (NASDAQ:HYZN) has reached a final resolution with the U.S. Securities and Exchange Commission (SEC) over a previously reported investigation. The company has agreed to pay a civil monetary penalty of $25 million in three installments. In Q2 2023, Hyzon accrued a $22 million loss contingency based on the SEC investigation.

Portfolio Pulse from Charles Gross

September 26, 2023 | 9:29 pm

GSUN

Golden Sun Education (GSUN) has received a Nasdaq notification letter regarding a minimum bid price deficiency. The company now has a compliance period to rectify this issue.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 9:05 pm

ITA

LDOS

LMT

Lockheed Martin Corp. (LMT) shares have seen a decline of approximately 9% month-to-date due to the looming risk of a U.S. government shutdown. Moody’s Investors Service warned that a shutdown could negatively impact defense service contractors, potentially affecting liquidity. However, it also noted that major prime contractors like Lockheed Martin and Leidos Holdings, Inc. (LDOS) have strong capabilities to manage payment delays effectively. The iShares U.S. Aerospace & Defense ETF (ITA) also registered a 9% decline.

Portfolio Pulse from Piero Cingari

September 26, 2023 | 9:01 pm

SPY

The U.S. Senate has proposed a short-term spending bill that would fund the U.S. government through November 17, according to Reuters citing Punchbowl. This could potentially impact the SPY ETF.

Portfolio Pulse from Charles Gross

September 26, 2023 | 8:59 pm

RPID

Rapid Micro Biosystems has regained compliance with the Nasdaq bid price requirement, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 8:47 pm

GNFT

GENFIT's non-alcoholic steatohepatitis (NASH) diagnostic technology NIS4® has been confirmed for its effectiveness in a study published in Nature Medicine. The study, part of the FNIH Biomarkers Consortium's NIMBLE project, evaluated five blood-based panels, including NIS4®. The findings concluded that NIS4® demonstrated significant superiority over common clinical-laboratory tools for diagnosing at-risk NASH. These findings represent an important milestone in NIS4® technology's path to regulatory approval by the U.S Food and Drug Administration.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 8:24 pm

DHC

OPI

RMR

Diversified Healthcare Trust (DHC) has announced changes to its Board of Trustees and executive leadership team, including the appointment of Phyllis Hollis as an Independent Trustee and Matthew Brown as CFO. DHC has also engaged B. Riley Securities as its financial advisor to address near term capital needs and pending debt maturities. DHC is currently not in compliance with debt incurrence covenants and has $700 million in debt maturing in 2024. The company is considering raising new capital and selling assets to address its capital needs.

Portfolio Pulse from Happy Mohamed

September 26, 2023 | 8:23 pm